Autopsy report · NCT02266433

Dexamethasone Versus Ketorolac Injection for the Treatment of Local Inflammatory Hand and Upper Extremity Disorders

“due to PI's change to private practice”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 1 month after it had already started.
• Ran for about 5 years 11 months before it stopped.
• 245 participants enrolled.
• Results were posted on the registry 2 years 4 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

NYU Langone Health

Sponsor type

University, hospital or other

Conditions

DeQuervains Tenosynovitis; Lateral Epicondylitis; Tennis Elbow; Trigger Finger; Tenosynovitis; Inflammatory Disease

Interventions

Ketorolac; Dexamethasone

Participants

245

Sites

1

Countries

United States

Trials that died the same way

• Investigational TMS Treatment for Depression
  “PI's discretion due to needing to modify study protocol.” (72% match in meaning)
• Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth
  “PI no longer in practice.” (69% match in meaning)
• Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
  “PI changed institutions” (64% match in meaning)
• Ultra High Field MRI of Focal Pediatric Epilepsy
  “PI moved to a different institution.” (63% match in meaning)
• Pre-post Spinal Popliteal Block
  “Retrospective study that the PI decided not to proceed with” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.